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Abstract
Background
Clinical trials require high levels of participation and low drop-out rates to be successful.
However, collecting blood samples from individuals recruited into clinical trials can be chal-
lenging when there is reticence about blood-taking. In addition to concerns regarding the
feasibility of medical research, fears of ‘blood-stealing’ and ‘blood-selling’ have ethical impli-
cations related to cultural sensitivity and informed consent. This study explores anxieties
around blood-taking during a malaria treatment trial in the Gambia.
Methods
This case study is based on ethnographic research in one theoretically selected village due
to the high reticence to screening for the clinical trial ‘Primaquine's gametocytocidal efficacy
in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine’ carried out in
the Gambia between 2013 and 2014. Data collection tools included in-depth interviews, par-
ticipant observation, informal conversations and group discussions.
Results
In total only 176 of 411 habitants (42%) in the village accepted having a bloodspot taken to
screen for malaria. Although trial recruitment was initially high in the village, some families
refused screening when rumours started spreading that the trial team was taking too much
blood. Concerns about ‘loss of blood’ were equated to loss of strength and lack of good food
to replenish bodily forces. Families in the study village were concerned about the weakness
of their body while they had to harvest their crops at the time of recruitment for the trial.
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Conclusion
A common recommendation to prevent and avoid rumours against public health interven-
tions and trials is the provision of full and consistent information during the consent proce-
dure, which is assumed to lead to more accurate knowledge of the purpose of the
intervention and increased trial participation. However, even when information provision is
continuous, the emergence of rumours can be related to times of uncertainty and percep-
tions of vulnerability, which are often a reflection of structural inequalities and diverging
value orientations between communities and public health institutions.
Introduction
Background
Medical research involving human subjects has increased substantially over the last decades
[1,2]. Although the number of clinical trials conducted in Sub Saharan Africa is lower than in
Europe and the United States, their number has grown significantly, a consequence of the
higher availability of resources for public health-orientated research and the need to address
the high burden of diseases in these countries [1,2].
Clinical research is regulated by internationally agreed ethical principles, formulated into
guidelines, national laws and regulations [3–5]. Nevertheless, the ethical conduct of research
specific to developing countries has been subject to discussion [6–8]. People’s decision to par-
ticipate in medical research and clinical trials in Sub Saharan Africa can be influenced by the
perceived benefits [7] and the level of trust patients place on investigators [1,9]. Furthermore,
potential trial participants’ understanding of research methods, such as blinding and randomi-
zation, and perceptions of risk can influence the decision to participate [1]. Even when proce-
dures are guided by approved protocols and followed by the book, collecting blood or other
bodily samples from individuals recruited into clinical trials can be challenging when rumours
arise [10–13]. Fears of blood-stealing, body parts trade, sterilization campaigns and the deliber-
ate spreading of diseases in relation to public health interventions have been documented since
colonial times [10,13–15], and continue to influence medical research and clinical trials [6,12].
When rumours arise, investigators often respond by intensifying community sensitization
and providing additional information. At times, research participants and influential members
of the community are taken to the clinic and to the laboratories to demonstrate scientific proce-
dures. Such measures are often facilitated by fieldworkers who speak the local languages and
are able to explain the scientific procedures. Some trials strongly encourage the placement of
fieldworkers in the study villages and thus fieldworkers often reside in trial participants’ homes
[16]. This seems to have a positive effect on trial participation since misunderstandings and
emerging rumours can be dealt with immediately. However, this can also have ethical implica-
tions when villagers agree to participate on the basis of friendship, social kinship and trust,
rather than with the intention to contribute to the advancement of science and medical
research [16–18].
Clinical trials require maximum participation and low drop-out rates to be successful
[6,19,20]. An improved understanding of potential study participants’ concerns and beliefs
about blood-taking in medical research could improve free and informed decision-making for
potential participants and enhance the overall trust relationship between medical institutions
and research participants [1]. This case study explores anxieties around blood-taking as a rea-
son for reticence towards screening for the inclusion in a malaria treatment trial in one village
in rural Gambia.
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Methods
Study design
The presented research is a case study. Case studies can be defined as ‘an empirical inquiry that
investigates a contemporary phenomenon within its real-life context; when the boundaries
between phenomenon and context are not clearly evident; and in which multiple sources of evi-
dence are used’ [21]. It allows for an in-depth understanding of ‘how’ and ‘why’ rumours about
blood-sampling emerged, and takes into account the local context [22,23].
This case study used an ethnographic approach. Qualitative data were gathered by triangu-
lating in-depth interviews, focus-group discussions, and participant observation, including
informal talks during fieldwork, in order to enhance the reliability and validity of emerging
results. Sampling was theoretical and analysis was a process concurrent with data collection in
line with a grounded theory approach[24].
The case study was ancillary to the trial ‘Primaquine's gametocytocidal efficacy in malaria
asymptomatic carriers treated with dihydroartemisinin-piperaquine’ (ClinicalTrials.gov:
NCT01838902) (hereafter, Prinogam), evaluating the effect of different doses of primaquine to
clear gametocytes. This health facility based trial was carried out in the Upper River Region
and the Central River Region during the 2013 and 2014 rainy seasons [25]. The initial pre-
screening was done to determine infection (rapid antigen test kit) and to establish a baseline
parasitaemia (microscopy). The pre-screening took place in 56 villages.
For the anthropological case study, a Fula village was theoretically selected from 12 villages
in which ethnographic fieldwork during the Prinogam trial took place. The selection was based
on the substantial reticence in the village, in comparison to other villages participating in the
Prinogam trial. The study took place in November and December 2013 and in August 2014.
Ethnographic research methods were employed to understand reasons for low participation.
Study site and population
The selected village for the case study comprises 12 compounds located about an hour’s drive
south east of Basse, where the Medical Research Council Gambia (MRCG) field station is
located. It is two kilometres away from the border with Senegal. According to the census data
of 2013, 411 individuals were officially registered as residents, some of whom were absent at
the time of screening (see Table 1). All inhabitants were Fulani and lived off cattle herding and
subsistence farming (predominantly millet, maize, groundnuts and rice) as well as remittance
from family members living in urban areas or from relatives living abroad. There was no
Table 1. Socio-demographic characteristics of participants (N = 30).
Men Women
n n
Occupation
Elderly (retired) 3 3
Alkalo (village chief) 1 0
Policeman 1 0
Marabout (traditional healer) 1 0
Imam 1 0
Herder 5 0
Farmer/housework 3 10
Traditional birth attendant 0 2
Total 15 15
doi:10.1371/journal.pone.0160464.t001
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electricity in the village and inhabitants fetched water from a nearby well. For healthcare and
business, participants either went to Madina Samako, a large village nearby, or to Velingara in
Senegal. Basse was perceived to be less accessible and transport less affordable.
The principal malaria parasite in The Gambia is Plasmodium falciparum, which is transmit-
ted by three mosquito species of the Anopheles gambiae complex [26]. Malaria transmission is
moderate and highly seasonal, starting during the short rainy season (June-September) and
peaking from November until December/January. Malaria prevalence is heterogeneous, with
the eastern part of the country having the highest prevalence [27].
Research on treatment-seeking-behaviour for malaria in the Gambia found that in 2003,
63% of respondents took their children to the health centre for malaria treatment and 13% to a
health village post [28]. Wiseman et al. (2008) found that 48.6% of respondents went to the
hospital for malaria treatment, 21.7% to the health centre and 4.5% to the clinic [29]. Recent
evidence suggests that treatment seeking depends on the symptoms, perceptions of the cause
and severity as well as the development of the malaria episode, the healing process or the lack
of recovery. Patients do not necessarily go to the health centre if they interpret the symptoms
of the illness as a self-limiting febrile illness or a folk illness (Jontinooje/Kajeje)[30]. A visit to
the health centre is often delayed until the patient is seriously sick [30].
The Prinogam trial
The case study was part of the Prinogam trial in which the following procedures were followed:
Community sensitization. In agreement with the village chiefs and the village councils,
sensitization meetings were held before any research activity started. All inhabitants of the vil-
lage were invited. At these meetings the purpose of the study and the procedure were explained
in detail by the study team, consisting of fieldworkers and nurses from the MRCG.
Screening. The Prinogam study team moved from compound to compound and verbal
consent was taken for a rapid clinical assessment and a Rapid Diagnostic Test (RDT) (pre-
screening). Blood from a single finger prick from all non-febrile people was used to prepare a
blood slide and perform an RDT. If the RDT was negative, the blood slide was discarded and
the person was told that they did not have malaria. Otherwise, the blood slide was taken to the
laboratory, stained and read by microscopy to determine the parasite density. Participants with
a Plasmodium falciparummono-infection with a density of at least 20 parasites/μL were
informed of the result and invited to be taken to the clinic with the MRCG car the following
day. After obtaining the written informed consent, a finger prick blood sample was collected
for haemoglobin (Hb) measurement using a handheld machine (Hemocue1) and G6PD
screening by the fluorescent spot test (SQMMR500, R&D Diagnostics). If eligible, participants
were referred to the trial clinician for randomisation and enrolment.
Enrolment, treatment and follow up. After successful screening, consent (day 0) and
clinical review, each participant was randomized into one of the four study groups and fol-
lowed up on days 1, 2, 3, 7, 10, 14, 21, 28, 35, and 42 or on any other day outside scheduled vis-
its if they felt sick. At each visit, a blood sample (about 0.5ml by finger prick) was collected for
the determination of gametocytaemia (QT-NASBA), parasite clearance (blood film and PCR)
and Hb. In addition, a venous blood sample (3ml) was collected from a subset of 100 partici-
pants that consented for a direct membrane feeding assay to determine infectiousness to mos-
quitoes on day 7 (for more details see [25].
Qualitative data collection
Participant observation. Participant observation is a key method in ethnographic
research [31]. It involves participating in everyday activities in the community setting,
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observing events in their usual context and carrying out reiterated informal conversations with
a maximum variety of research subjects. This method provides a more contextualised under-
standing of the research questions and helps cross-check the validity of the information
obtained in semi-structured interviews. Participant observation reduces biased responses in
interviews. Establishing a rapport and certain level of trust with the research participants is
central to participant observation in ethnographic fieldwork. For this research, the main author
and fieldworkers repeatedly visited and stayed in the village for a few days at a time over a time
period of one year. During these stays, people’s everyday routines were observed, trust was
established and informal conversations about relevant themes (i.e. the trial, the MRCG, blood,
health and malaria) were held. Informal conversations were conducted in English and Fula and
written down after the interview as soon as appropriate.
In-depth interviews. In-depth interviews were conducted at participants’ residences in
private or in places where they felt most at ease. In total 30 interviews were conducted
(Table 1). All formal in-depth interviews were recorded at this site and translated with the
assistance of trained field assistants. These interviews were fully transcribed. The interviewees
were visited and informally interviewed again on various occasions after the formal recording.
Group discussions. Two group discussions were conducted. The first (i) comprised a
group of women who were looking after children in the same compound; this group discussion
was about trial participation, the MRCG and blood-taking. The second (ii) was a group of men
resting together at the bantaba (central meeting place). This discussion was about the history
of the village, social structure and politics. The participation of various members enriched the
data by providing different points of view in a discussion.
Sampling
Participant recruitment was carried out through a mixed-sampling approach, including both
purposive and snowball sampling techniques. Informants were purposively selected based on
the questions emerging from the on-going analysis of collected data. Respondents were selected
to ensure that all social groups were represented (maximum variation), regardless of local hier-
archy or locally perceived expertise. In addition, snowball sampling was used to enhance par-
ticipants’ trust and confidence in the research team when information was needed on sensitive
subjects. Information about the respondents was collected and categorized in relation to rele-
vant criteria, such as gender, age, social standing, trial participation and refusal, and role within
the village [32].
Data analysis
Data analysis was concurrent to data collection using a constructivist grounded theory
approach [32]. Key analytic concepts in ethnographic research such as reflexivity, positionality
and subjectivity were considered during the ethnographic fieldwork as well as during the data
analysis. Relevant categories for analysis were established during the field research based on
the participant observation, interviews and group discussions. Once patterns and themes rele-
vant to the research question emerged, the results were constantly tested for their validity by
including and confirming or refuting critical cases. The verification and validation of the results
took place by systematically interviewing people belonging to different socio-demographic cat-
egories on the same topic, e.g. men versus women; trial participants versus non-participants;
high versus low status groups. Once data saturation was reached for recurrent themes during
the fieldwork, the results were further analysed and categorised after the transcription process.
For the coding and analysis, the principle of retroduction was used combining inductive analy-
sis from field data and theory from existing anthropological literature[24]. An initial coding
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framework was set up and further deepened through open coding. The analyses were carried
out by means of a careful reading of the coded text fragments and with attention to potential
interrelations. Through the analysing process data were constantly subjected to theoretical per-
spectives as to ensure theoretical triangulation and to embed the findings in existing literature.
Data were imported, managed and analysed using NVivo 12 Qualitative Data Analysis software
(QSR International Pty Ltd. Cardigan UK).
Ethical considerations
The social science study was approved by the Gambia Government/MRC joint Ethics Commit-
tee (SCC number 1351) and the Institutional Review Board of the Institute of Tropical Medi-
cine, Antwerp, Belgium (880/13). The interviewers followed the Code of Ethics of the
American Anthropological Association (AAA). All interviewees were informed of the study,
the type of questions to be asked and the intended use of the results prior to the interview. Ano-
nymity and confidentiality were guaranteed and they were informed that they had the right to
refuse or stop the interview any time. Verbal instead of written consent was preferred as
requesting the subject’s signature could have been a potential reason for mistrust. A witness
acknowledged the verbal consent and signed a documentation of consent sheet.
For ethical reasons and in order to avoid potentially negative repercussions for village
inhabitants in the future (e.g. stigma), the name of the village and further details on the study
subjects have been omitted from the manuscript.
Results
Details of screening and refusals
Among the 411 inhabitants of the village, 174 were approached and pre-screened for the trial.
43 people were absent or had moved away from the study area; 39 were not eligible because
they were pregnant, breast-feeding or too old; 3 individuals refused to be screened and 149
were not pre-screened because the compound heads refused screening for the entire compound
(5 out of 12 compounds) (Table 2).
Although initially recruitment went smoothly, after one month the Prinogam study team
encountered problems when no one wanted to be screened and some people refused to go to
the hospital for follow-up.
Table 2. Details on pre-screening of Fula case study villages within the Prinogam study.
n %
Status of pre-screening (N = 411)
Screened 174 42.3
Not screened 237 57.7
Reason not screened (N = 237)
Travelled (absent) 40 16.9
Moved outside study area 3 1.3
Exclusion criteria: 42 17.7
- Breast feeding 30 12.6
- Pregnant 4 1.7
- Too old (not being able to walk or give consent) 5 2.1
- Other reasons 3 1.3
Individual refused 3 1.3
Whole compound refused 149 62.8
doi:10.1371/journal.pone.0160464.t002
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Reasons for refusal of blood sampling
Conceptions of blood as reasons for non-participation. The main reason for refusing
participation was “blood taking”. Some trial participants spread the news that a lot of blood
was taken at the hospital, which instigated rumours in the village leading to a sudden halt in
screening due to the villagers’ complete refusal to participate. The given reason was fear of loss
of strength through loss of blood, the latter associated with depleting life-force and body
strength. Although people were told and had understood that the blood was taken to see if the
person had malaria or not, most respondents believed that loss of blood was worse for a per-
son’s health than the presence of malaria in the body. It was thought that the blood taken could
not easily be replenished.
Blood as a life-force. Blood was inextricably linked to being alive and to health. Sickness
was associated with lack of blood in the body, as illustrated in the following quote:
“The importance of blood is infinite. Blood is very, very important. Even for us here, who
are sitting here talking, we are only able to do so because we are in good health. We are with
the health that God lent us. No one can over-emphasize the importance of blood. When a bit
of blood is missing from your body, you cannot be anything. It will affect some people’s brain,
there is nothing negative that has not been said about blood taking.” (Elderly herder)
“For me when you talk about blood I think straight away about life because without blood,
life will be very difficult to achieve. If you fall sick you might need blood because I think it cir-
culates all over the body.” (Middle aged herder)
In respondents’ discourses, blood and work were closely linked. A person was thought not
to be able to achieve much in life if the quality of their blood was not good. If a person was not
able to endure long working hours on the fields or in the bush it was thought to be linked to
their blood.
Nutrition and blood. Different conceptions of the ‘quality’ and ‘quantity’ of blood existed,
which were linked to nutrition. Respondents reiterated that although they had ‘enough blood’
the ‘quality’ of their blood was not good because they were not eating well. People believed that
their diet, which was almost entirely based on subsistence farming and herding, was not
healthy. In order to replenish the strength lost through hard work, farming, cattle-herding or
blood taking, more nourishing food was needed. The types of food that were thought to pro-
duce blood in the body were meat, oily food and rice.
“For us here, currently people are not strong because we are fully depending on cow milk.
The groundnuts are just ripening. We don’t eat oil or meat; we only eat the fish people bring
here for sale. We only eat our village food so where should we expect to get blood from? Even if
you take our blood and put it in a small bottle it will cause us problems.” (Elderly woman)
“It’s because in the village here, the diet we take is in between bitterness and sourness and
you know that cannot add blood in the body, our ways of surviving are not the same. Now if
you are not surviving on a good diet and your blood isn’t much and people want to reduce that
blood from you, it is going to be a problem. That is why most of the time, people in the village
resist for their blood to be taken from them. If only you have enough money to eat good diets,
diets that will give you vitamins, you will not be scared.” (Elderly herder)
“Before giving us food to replace the blood taken from our body, why don’t you just leave
the blood that is in our body? [laughing] We are farmers and we don’t have blood. But right
now the groundnuts are ripening and after eating enough groundnuts, if you take our blood we
will not feel it. (. . .) You know, Fulas don’t like eating too much meat because they cannot buy
it. We fully and surely depend on milk.” (Elderly woman)
Blood as fuel. It became evident from respondents’ explanations that the ‘quantity’ of
blood was crucial for strength, which was thought to be needed on a day-to-day level to
Conceptions of Blood and Fear of Trial Participation in Rural Gambia
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undertake the work necessary for subsistence farming. The more blood a person was thought
to have, the stronger and more enduring they were believed to be farming “under the hot sun”
or herding animals in the bush. If a person worked hard under the sun for extended periods of
time, their blood was thought “to burn like fuel”, making him/her more vulnerable to weakness
and sickness:
“(. . .) When your blood is taken and you have a lot of work to do in the sun, your blood will
burn very well and that will make you scared so that for a few days you will not work. You will
be asked to rest.” (Young herder)
Interviewer: “What is so important about blood? Is it that when you lose blood you will lose
strength or do you think people can use the blood for evil?”
Respondent: “It is the strength you will lose of course because you see, even a car, it requires
both petrol and water, if there is no water in the car it will obviously not go. Just like the petrol,
if there is no petrol in the car it won’t go either. Is it not like that?” (Middle aged herder)
Blood and gender. Women were generally perceived to be more vulnerable to weakness
than men because of pregnancy, child-birth and menstruation. Blood-donation was thought to
be impossible due to health risks to the mother and the unborn child. Pregnancy was believed
to last for at least eight months, in some cases up to two years. Thus it was thought that blood-
taking was very bad for pregnant women, particularly those who had young children.
“I don’t know whether they don’t have enough blood but a woman is always giving birth. A
woman who gives birth to a lot of children, if she gives out her blood, you know, that will be a
problem. I am not saying that this is the case if you are not giving birth or when you have
stopped giving birth. A woman cannot just start giving birth and give out blood, that is the
problem.” (Elderly woman)
Blood testing, blood donations and blood stealing. People did not conceptually distin-
guish between blood sampling for testing and blood donation. Although the trial procedure
and eligibility criteria of the trial had been explained on numerous occasions, many people
seemed to think that some of the blood taken during the trial would be donated to someone or
potentially sold. Although many of those enrolled in the trial said that too little blood was
taken for the MRCG to use for other purposes and that they had seen them “check the blood
with a machine”, those who refused to participate stated they did not have enough “blood to
give away”. The following elderly herder compares trial participation to an event in his life
when he was asked to donate blood:
“They asked me to donate two litres of blood but I insisted and only gave them a litre
because that was what my daughter needed. But today with the condition that I am in, I know
perfectly well that I cannot donate anyone even a litre of blood, I don’t have that amount of
blood in my body because I really do know myself. My body is very weak as I am now.” (Elderly
herder)
These beliefs arose particularly because the MRCG was not recruiting the ‘sick’ with malaria
but asymptomatic carriers who were perceived to be completely healthy. Some believed that
the drugs given to ‘healthy people’ were to make up for blood loss.
“. . . they say that if you are taken to the hospital, they will take your blood and in return the
only thing they give you back is medicine, and we are told that this medicine is to replace the
blood that has been taken from your body and that’s all they give you. They also said that you
people are only after healthy people, those whose blood is good and healthy are the people you
are after. You are not after the sick, and they are saying all that.” (Middle aged herder)
People believed that medical institutions, such as the MRCG, as well as hospitals in general
would take more blood if they could get away with it. For some, it seemed a question of weigh-
ing up the benefits of trial participation against the risk of having one’s blood taken, which
would then probably be sold or donated to someone else or used for sorcery.
Conceptions of Blood and Fear of Trial Participation in Rural Gambia
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Perceived risks of blood-taking. In addition to the more abstract conceptions of health
and sickness as being linked to the quality of the blood, some respondents expressed more con-
crete fears related to blood-taking, such as losing so much blood that they would have to be
hospitalised due to lack of blood, which would then require them to buy someone else’s blood:
“People are only suspicious of one thing and that is the issue of blood. So if you are taken to
the hospital, and you don’t have enough blood, if they want to take your blood then you will be
scared. Because if I lack blood today and I am taken to the hospital it may cost me a million to
get blood, or 1500 Dalasi, 1000 Dalasi, or 500 Dalasi. The issue of blood is very hard and diffi-
cult. So this is the reason why people are suspicious of their blood being taking, if you need
more blood and the little you have is about to be taken, you will obviously be scared.” (Middle
aged herder)
Symptoms of weakness that were perceived to be linked to loss of blood were dizziness and
loss of consciousness:
“I have seen many people, when their blood is taken or reduced they will faint and every-
thing will be black in the person’s eyes. That is the problem. But there are some people who,
when their blood is high, will make a request for their blood to be reduced and nothing will
happen to the person.” (Elderly woman)
The latter quotation demonstrates the common belief that high blood pressure can be reme-
died through blood taking. It is thought that those suffering from high blood pressure should
have their blood reduced regularly and that blood taking does not affect them in the same way
as those who “do not have a lot of blood”.
Discussion
The refusal to participate in public health campaigns or clinical trials in both African and Euro-
pean settings is commonly interpreted as caused by a lack of, or misunderstanding of the pur-
pose of the intervention. ‘Myths’ and ‘rumours’ are often treated as irrational residues and by-
products of people’s insufficient knowledge about new technologies and practices [33]. Addi-
tional documented factors leading to rumours are the lack of trust in public health institutions
[33–35] and stigma related to trial participation [20]. This case study’s results show that con-
cerns about daily subsistence and vulnerability related to poverty can also contribute to reti-
cence. Those who refused were afraid of losing life-force and strength, which they associated
with the quality of their blood. Particular concerns regarded the necessity to increase the quan-
tity of blood in their body to restore strength. Previous research in the study region found that
people evaluated different kinds of food in terms of their impact on blood and some foods are
particularly sought after because they are thought to replenish blood and strength [36,37].
Those who refused to participate believed that the research team was going to give the blood to
others and that they would be left weak, bloodless and vulnerable to sickness. Such beliefs
seemed to be linked to the fact that only apparently ‘healthy’ people were being recruited in the
trial and not those who were sick. Refusers felt that they were not in a position to “give away”
their blood because they did not have enough and were afraid of getting sick if they lost more
strength and, as a consequence, might need to get hospitalized and purchase blood for them-
selves. These findings are in line with Fairhead and Leach who describe that many people
believe that blood taken during trials is later sold [11,36]. Cham (2003) described how, more
than 12 years ago, patients in need of blood in The Gambia were given different options: either
to receive blood from a close relative with the same blood group, or to buy blood for cash [38].
Such accounts may partially explain current blood-selling perceptions.
Vulnerability is a term commonly used to describe the dialectical relationship between pov-
erty, risk and efforts to manage risks [39–42]. Locally perceived risk is socially constructed and
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depends not only on the nature of a hazard but also on political, social and cultural contexts
[43,44]. Rather than solely being due to ignorance and misunderstanding, reluctance to partici-
pate may instead be linked to distinct forms of experiential expertise grounded in everyday
practice, knowledge and epistemology [11,45]. It has been shown that in different socio-cul-
tural contexts people feel vulnerable to different health problems, which do not always corre-
spond to the calculated probability of epidemiological risk [46]. ‘Vulnerability refers to the
actual feeling of susceptibility to illness or misfortune. It is a state of weakness, fear and worry’
[47]. In everyday language, risk is an expression of hazard, chance and uncertainty. In devel-
oped as well as in developing countries people think about and engage with risk and vulnerabil-
ity in different ways. Whereas some members of an epidemiological risk group may not
perceive themselves as vulnerable at all, for others exposure to risk data may trigger a sense of
vulnerability [47]. As Gikonyo et al. [47] argued, locally perceived risks are often far greater
and more dramatic than the biomedical risk mentioned in the informed consent procedures.
In this study, the actual risk of taking a finger-prick of blood were minimal/non-existent but it
was nevertheless perceived as potentially dangerous in the study village, clearly associated to
perceptions of risk linked to poverty, lack of resources and possibly fear of exploitation. The
fears around risk and threat to health, point to a social reality that needs to be addressed in
informed consent procedures, public health research and policy planning.
It is not clear why these concerns reached the tipping point of non-participation in this
study village, while there were few concerns about blood taking and trial participation in other
Prinogam trial villages and research shows that people are often very keen to participate in clin-
ical trials conducted by the MRCG in the Gambia [9]. The concrete results of this case study
can therefore not be directly generalized to other trial villages in the Gambia. Nevertheless,
individual reticence to trial participation in other places may also be linked to fear of blood tak-
ing due to depletion of life-force and fear of exploitation. Rumours can affect overall participa-
tion rates in research and disease elimination strategies. Further research might focus on how
perceived risks can be appropriately addressed and discussed, for instance during the informed
consent procedures.
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